Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Abiomed Inc.

Start price
Target price
Perf. (%)
€266.60
29.04.21
€245.00
29.04.22
-10.43%
07.06.21

Could be worthwhile Investment >10% per year
MicroVision Inc

Start price
Target price
Perf. (%)
€24.88
27.04.21
€20.00
27.04.22
-24.96%
27.04.21

Capable Management
Probably not worthwhile Investment
Few uniques
Sartorius AG VZO

Start price
Target price
Perf. (%)
€468.70
16.04.21
€440.00
16.04.22
-18.50%
17.04.22

Probably not worthwhile Investment
Very low/no dividend yield expected
buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€73.50
15.04.21
€88.00
15.04.22
10.48%
03.05.21

Could be worthwhile Investment >10% per year
buy
bioMerieux S.A.

Start price
Target price
Perf. (%)
€111.90
12.04.21
€120.00
12.04.22
-3.84%
07.11.21

Could be worthwhile Investment >10% per year
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€22.15
12.04.21
€28.35
12.04.22
-51.96%
24.12.21

Could be worthwhile Investment >10% per year
buy
Vivani Medical Inc.

Start price
Target price
Perf. (%)
€24.60
06.04.21
-
06.04.22
-34.15%
03.05.21

Good rating
Capable Management
Probably not worthwhile Investment
No Innovation
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€158.00
04.04.21
€75.00
04.04.22
-56.02%
05.04.22

Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Good rating
ROE higher than 10% per year
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€163.98
20.03.21
-
20.03.22
-46.87%
21.12.21

Could be very worthwhile Investment >20% year
Vivani Medical Inc.

Start price
Target price
Perf. (%)
€26.55
10.03.21
-
10.03.22
-86.89%
11.03.22

Lower EBIT Margin than peer group
High valuation
Low dividend yield expected
negative Cash Flow expected
buy
Agilent Technologies Inc.

Start price
Target price
Perf. (%)
€101.00
09.03.21
€120.00
09.03.22
19.46%
10.03.22

Could be worthwhile Investment >10% per year
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€61.80
08.03.21
-
08.03.22
-21.91%
09.03.22

buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€61.80
08.03.21
-
08.03.22
-26.29%
09.03.22

Vivani Medical Inc.

Start price
Target price
Perf. (%)
€24.00
08.03.21
€15.00
08.03.22
32.50%
20.03.21

Good rating
Capable Management
Probably not worthwhile Investment
No Innovation
buy
Stratec SE

Start price
Target price
Perf. (%)
€116.60
03.03.21
€165.00
03.10.22
3.43%
06.04.22

Could be worthwhile Investment >10% per year
buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€57.94
01.03.21
-
01.03.22
-2.93%
02.03.22

buy
Hologic Inc.

Start price
Target price
Perf. (%)
€62.50
24.02.21
-
24.02.22
1.60%
30.03.21

Probably not worthwhile Investment
Teleflex Inc.

Start price
Target price
Perf. (%)
€320.00
21.02.21
-
21.02.22
14.38%
23.04.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
buy
Vita 34 AG

Start price
Target price
Perf. (%)
€15.55
21.02.21
-
21.02.22
-25.08%
22.02.22

Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€4.22
21.02.21
-
21.02.22
-5.21%
06.03.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Pixium Vision S.A.

Start price
Target price
Perf. (%)
€1.03
17.02.21
€3.00
17.02.22
-24.32%
25.12.21

Could be very worthwhile Investment >20% year
Leading role in innovation
Future proof or reliable business model
buy
Dexcom Inc.

Start price
Target price
Perf. (%)
€82.24
09.02.21
€87.50
09.02.22
29.20%
12.08.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Sustainability is important
Higher risks for its business
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€34.83
08.02.21
€41.00
16.07.21
27.92%
16.07.21

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
CRH Medical Corp

Start price
Target price
Perf. (%)
€3.22
08.02.21
€3.00
08.02.22
-0.62%
22.02.21

Good culture
Probably not worthwhile Investment
Little innovation
No uniques
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€3.44
08.02.21
€5.00
08.02.22
-27.31%
22.02.21

Could be worthwhile Investment >10% per year